Patients with Moyamoya disease have abnormal intracranial blood vessels [Online Resource 1], the presence of which results in frequent strokes. Anesthesia further enhances the risk. We report cerebral oxygen saturation (rSO 2 ) observations using noninvasive near-infrared spectroscopic (NIRS) cerebral oximetry during a cesarean delivery (CD) under combined spinal epidural anesthesia in a Moyamoya case.
To the Editor:
Patients with Moyamoya disease have abnormal intracranial blood vessels [Online Resource 1] , the presence of which results in frequent strokes. Anesthesia further enhances the risk. We report cerebral oxygen saturation (rSO 2 ) observations using noninvasive near-infrared spectroscopic (NIRS) cerebral oximetry during a cesarean delivery (CD) under combined spinal epidural anesthesia in a Moyamoya case.
A 30-year-old G 1 P 0 Moyamoya patient had an elective CD at 37 weeks. Her rSO 2 was monitored using an NIRS cerebral oximeter. Eight milligrams of intrathecal heavy bupivacaine was sufficient for an optimum block. An intravenous bolus of 5 IU oxytocin at a volume of 5 ml was injected over a span of 1 min immediately following the delivery. Her rSO 2 remained normal (60-75 %) and was relatively higher after the delivery [Online Resource 2] . We postulate that the increase in rSO 2 after the delivery resulted from oxytocin-induced cerebral vasodilatation.
Oxytocin leads to dilatation or constriction in a myriad of blood vessels [1] . It has a vasopressin-like weak vasoconstrictive effect, and some reports [2] suggest that it may reduce cerebral blood flow (CBF), although other articles suggest an increase in CBF in experimental animals [3] . The rSO 2 monitoring in obstetric anesthesia is currently scarce. We propose that rSO 2 should be monitored in Moyamoya patients undergoing anesthesia, particularly when oxytocin is administered.
